CapForce Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $50.1M
- Price
- $4.04
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.25%
- Volume
- 744
About
CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.
Quick stats
Shares outstanding12.4M
Computed float2.4M
Float / shares19.7%
Key info
SectorFinancial Services
IndustryFinancial - Capital Markets
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001293818
Websitehttps://www.capforce.inc
AI Summary
AI-generated3d agominorneutralother
OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
CapForce Inc. (OTCQB: CFOR) is scheduled to present at the third annual Global Markets Forum on Thursday, October 8, 2026, at 10:00 AM ET as part of the virtual company presentation session.
The two-day forum is organized by Virtual Investor Conferences in partnership with OTC Markets Group, Aquis Stock Exchange, BME, the Canadian Securities Exchange, and SIX Swiss Exchange, and features C-suite presentations and one-on-one investor meetings.
This is a routine investor-visibility appearance with no new financial or operational disclosure from CapForce; expect minimal direct market impact.